S
SGMO

SignatureFD’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

SignatureFD’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,424
Closed -$28.9K – 3353
2023
Q1 		$28.9K Buy
16,424
+4,650
+39% +$13.3K ﹤0.01% 1669
2022
Q4 		$37K Buy
11,774
+10,132
+617% +$39.3K ﹤0.01% 1500
2022
Q3 		$8K Buy
1,642
+1,271
+343% +$6.53K ﹤0.01% 2204
2022
Q2 		$2K Buy
371
+189
+104% +$817 ﹤0.01% 2798
2022
Q1 		$1K Buy
+182
New +$1.08K ﹤0.01% 3055
2021
Q2 		– Sell
-316
Closed -$4K – 3047
2021
Q1 		$4K Buy
+316
New +$4.26K ﹤0.01% 2276
2018
Q3 		– Sell
-588
Closed -$8K – 1991
2018
Q2 		$8K Buy
+588
New +$9.77K ﹤0.01% 1449

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SignatureFD's SGMO Position: Q2 2023 in Review

SignatureFD sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 16,424 shares — an estimated $28.9K sold.

SignatureFD first reported a position in SGMO in Q2 2018 and held it in 7 quarters. The position peaked at $37K in Q4 2022. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • SignatureFD reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • SignatureFD sold 16,424 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $28.9K.
  • SignatureFD first reported a position in SANGAMO THERAPEUTICS INC in Q2 2018 and held it in 7 quarters.
  • SignatureFD's SANGAMO THERAPEUTICS INC position peaked at $37K in Q4 2022.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on SignatureFD's 13F filing for Q2 2023, filed 1 Aug 2023.